Skip to content
DataLookout
Menu

XTENDNCT07365735

TearCare MGX™ System With and Without Warming Hold

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Results posted: Nov 13, 2026
    • Eligibility criteria expanded, about 45 words
    • Secondary endpoints: 5 to 8
    • Primary endpoint revised
  2. Minor Trial completed
    • Enrollment target: estimated 20 to confirmed 21
    • Primary and study completion dates changed from estimate of May 2026 to May 19, 2026
    v3
  3. Minor Trial status changed: Not Yet Recruiting → Active, Not Recruiting
    • Start date changed from estimate of Feb 2026 to Mar 17, 2026
    • Site contact updated
    • Study title shortened, about 7 words
    v2
  4. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Mean Difference Between Eyes in Meibomian Gland Secretion Score (MGSS)
Timeframe: MGSS used to calculate the difference in MGSS between eyes is obtained post-treatment at the procedure visit (Day 0).

Secondary (8)

Mean Change From Screening Visit Baseline in MGSS - Right Eye
Mean Change From Screening Visit Baseline in MGSS - Left Eye
Mean Change From Screening Visit Baseline in Meibomian Glands Yielding Any Liquid (MGYAL) - Right Eye
Mean Change From Screening Visit Baseline in Meibomian Glands Yielding Any Liquid (MGYAL) - Left Eye
Mean Change From Screening Visit Baseline in Meibomian Glands Yielding Clear Liquid (MGYCL) - Right Eye
Show 3 moreShow less
Mean Change From Screening Visit Baseline in Meibomian Glands Yielding Clear Liquid (MGYCL) - Left Eye
Subject Comfort During Expression of Second Lid
Ease of Expression

Arms and interventions

TearCare MGX with Warming HoldActive comparator

15 minute thermal treatment with TearCare MGX followed by 10 minute warming hold

TearCare MGX without Warming HoldActive comparator

15 minute thermal treatment with TearCare MGX without subsequent warming hold period

Devices: localized heat therapy

Sites

1 site in 1 country

  • Cleveland Eye ClinicBrecksville, Ohio, United States